Developing New Version Of Sputnik Vaccine Adapted To 'Omicron': Russia
NDTV
The Russian Direct Investment Fund (RDIF), which supported the vaccine's development by the state-run Gamaleya Center, said that the centre "has already begun developing the new version of Sputnik vaccine adapted to Omicron."
The backers of the Russian Covid-19 vaccine Sputnik V said Monday that the jab is effective against the new 'Omicron' coronavirus variant but they were also developing an adapted booster.
The Russian Direct Investment Fund (RDIF), which supported the vaccine's development by the state-run Gamaleya Center, said that the centre "has already begun developing the new version of Sputnik vaccine adapted to 'Omicron'."
"In an unlikely case such modification is needed, the new Sputnik 'Omicron' version can be ready for mass-scale production in 45 days," RDIF said in a statement.
"Several hundred million Sputnik 'Omicron' boosters can be provided to international markets already by February 20, 2022 with over 3 billion doses available in 2022."